Célia Hart

Celia Hart is a General Partner and Partner in Life Sciences at Supernova Invest since 2017, contributing to a leading venture capital firm in the French deeptech investment market with €260 million in assets under management. Prior to this, Celia held the role of Investment Director at CEA Investissement from 2005 to 2016, focusing on investments in start-ups across various high-tech sectors. Celia's earlier career includes positions at the European Radiation Synchrotron Facility in marketing and business development, as well as multiple roles at Cambridge Antibody Technology, including Head of Lead Optimisation and Senior Research Scientist. Academic credentials include a PhD in Chemistry and Molecular Biology from the University of Oxford and an MBA in Technology and Innovation from Grenoble Ecole de Management.